Pro Medicus PMCUF Stock
Pro Medicus Price Chart
Pro Medicus PMCUF Financial and Trading Overview
| Pro Medicus stock price | 119.31 USD |
| Previous Close | 118.64 USD |
| Open | 118.64 USD |
| Bid | 119.27 USD x 20000 |
| Ask | 131.14 USD x 30000 |
| Day's Range | 118.64 - 118.64 USD |
| 52 Week Range | 74.52 - 210.25 USD |
| Volume | 13 USD |
| Avg. Volume | 263 USD |
| Market Cap | 13.05B USD |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 65.91713 |
| EPS (TTM) | 1.81 USD |
| Forward Dividend & Yield | 0.49 (0.41%) |
| Ex-Dividend Date | September 8, 2026 |
| 1y Target Est | N/A |
PMCUF Valuation Measures
| Enterprise Value | 12.21B USD |
| Trailing P/E | 65.91713 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 49.87785 |
| Price/Book (mrq) | 38.559982 |
| Enterprise Value/Revenue | 46.675 |
| Enterprise Value/EBITDA | 62.163 |
Trading Information
Pro Medicus Stock Price History
| Beta (5Y Monthly) | 0.58 |
| 52-Week Change | -38.73% |
| S&P500 52-Week Change | 18.83% |
| 52 Week High | 210.25 USD |
| 52 Week Low | 74.52 USD |
| 50-Day Moving Average | 128.23 USD |
| 200-Day Moving Average | 116.98 USD |
PMCUF Share Statistics
| Avg. Volume (3 month) | 263 USD |
| Avg. Daily Volume (10-Days) | 140 USD |
| Shares Outstanding | 104.47M |
| Float | 53.32M |
| Short Ratio | N/A |
| % Held by Insiders | 48.95% |
| % Held by Institutions | 25.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.69 |
| Trailing Annual Dividend Yield | 0.58% |
| 5 Year Average Dividend Yield | 31.00% |
| Payout Ratio | 0.24450001 |
| Last Split Factor | 1002:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 101.39% |
| Operating Margin (ttm) | 77.02% |
| Gross Margin | 99.84% |
| EBITDA Margin | 75.08% |
Management Effectiveness
| Return on Assets (ttm) | 25.83% |
| Return on Equity (ttm) | 74.96% |
Income Statement
| Revenue (ttm) | 261.69M USD |
| Revenue Per Share (ttm) | 2.51 USD |
| Quarterly Revenue Growth (yoy) | 18.19% |
| Gross Profit (ttm) | 261.29M USD |
| EBITDA | 196.49M USD |
| Net Income Avi to Common (ttm) | 265.34M USD |
| Diluted EPS (ttm) | 1.81 |
| Quarterly Earnings Growth (yoy) | 48.29% |
Balance Sheet
| Total Cash (mrq) | 252.28M USD |
| Total Cash Per Share (mrq) | 2.42 USD |
| Total Debt (mrq) | 2.23M USD |
| Total Debt/Equity (mrq) | 0.5 USD |
| Current Ratio (mrq) | 6.852 |
| Book Value Per Share (mrq) | 3.0941403 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 127.48M USD |
| Levered Free Cash Flow (ttm) | 98.87M USD |
Profile of Pro Medicus
| Country | United States |
| State | VIC |
| City | Richmond |
| Address | 450 Swan Street |
| ZIP | 3121 |
| Phone | 61 3 9429 8800 |
| Website | https://www.promed.com.au |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 153 |
Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Q&A For Pro Medicus Stock
What is a current PMCUF stock price?
Pro Medicus PMCUF stock price today per share is 119.31 USD.
How to purchase Pro Medicus stock?
You can buy PMCUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pro Medicus?
The stock symbol or ticker of Pro Medicus is PMCUF.
Which industry does the Pro Medicus company belong to?
The Pro Medicus industry is Health Information Services.
How many shares does Pro Medicus have in circulation?
The max supply of Pro Medicus shares is 109.4M.
What is Pro Medicus Price to Earnings Ratio (PE Ratio)?
Pro Medicus PE Ratio is 65.91713000 now.
What was Pro Medicus earnings per share over the trailing 12 months (TTM)?
Pro Medicus EPS is 1.81 USD over the trailing 12 months.
Which sector does the Pro Medicus company belong to?
The Pro Medicus sector is Healthcare.
